These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 17192480)
1. Altered natural killer cells in type 1 diabetic patients. Rodacki M; Svoren B; Butty V; Besse W; Laffel L; Benoist C; Mathis D Diabetes; 2007 Jan; 56(1):177-85. PubMed ID: 17192480 [TBL] [Abstract][Full Text] [Related]
2. Identical twins discordant for type 1 diabetes show a different pattern of in vitro CD56+ cell activation. Goodier MR; Nawroly N; Beyan H; Hawa M; Leslie RD; Londei M Diabetes Metab Res Rev; 2006; 22(5):367-75. PubMed ID: 16572491 [TBL] [Abstract][Full Text] [Related]
3. Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes. Lee IF; Qin H; Priatel JJ; Tan R Eur J Immunol; 2008 Jan; 38(1):82-9. PubMed ID: 18085661 [TBL] [Abstract][Full Text] [Related]
4. [The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II]. Salozhin KV; Sura VV; Nasonov EL; Korneeva MN; Smirnova OI Ter Arkh; 1989; 61(10):104-6. PubMed ID: 2609254 [TBL] [Abstract][Full Text] [Related]
5. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388 [TBL] [Abstract][Full Text] [Related]
7. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis]. Guo KY; Mei JZ; Yao KT Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963 [TBL] [Abstract][Full Text] [Related]
8. Modelling KIR-HLA genotype disparities in type 1 diabetes. van der Slik AR; Alizadeh BZ; Koeleman BP; Roep BO; Giphart MJ Tissue Antigens; 2007 Apr; 69 Suppl 1():101-5. PubMed ID: 17445178 [TBL] [Abstract][Full Text] [Related]
9. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related]
10. The expression of human natural killer cell receptors in early life. Sundström Y; Nilsson C; Lilja G; Kärre K; Troye-Blomberg M; Berg L Scand J Immunol; 2007; 66(2-3):335-44. PubMed ID: 17635811 [TBL] [Abstract][Full Text] [Related]
11. NK cells and type 1 diabetes. Rodacki M; Milech A; de Oliveira JE Clin Dev Immunol; 2006; 13(2-4):101-7. PubMed ID: 17162353 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. Ostberg JR; Dayanc BE; Yuan M; Oflazoglu E; Repasky EA J Leukoc Biol; 2007 Nov; 82(5):1322-31. PubMed ID: 17711975 [TBL] [Abstract][Full Text] [Related]
13. Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy? Tan DB; Fernandez S; French M; Price P Clin Immunol; 2009 Jul; 132(1):63-70. PubMed ID: 19403337 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis. Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461 [TBL] [Abstract][Full Text] [Related]
16. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348 [TBL] [Abstract][Full Text] [Related]
17. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862 [TBL] [Abstract][Full Text] [Related]
18. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma. Armeanu S; Krusch M; Baltz KM; Weiss TS; Smirnow I; Steinle A; Lauer UM; Bitzer M; Salih HR Clin Cancer Res; 2008 Jun; 14(11):3520-8. PubMed ID: 18519785 [TBL] [Abstract][Full Text] [Related]
19. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation. Kreijveld E; van der Meer A; Tijssen HJ; Hilbrands LB; Joosten I Transplantation; 2007 Oct; 84(8):1045-51. PubMed ID: 17989611 [TBL] [Abstract][Full Text] [Related]
20. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Steinke JM; Mauer M; Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]